These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27230641)

  • 1. Vascular Complications of Diabetes.
    Beckman JA; Creager MA
    Circ Res; 2016 May; 118(11):1771-85. PubMed ID: 27230641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.
    Beckman JA; Paneni F; Cosentino F; Creager MA
    Eur Heart J; 2013 Aug; 34(31):2444-52. PubMed ID: 23625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral arterial disease in patients with diabetes.
    Marso SP; Hiatt WR
    J Am Coll Cardiol; 2006 Mar; 47(5):921-9. PubMed ID: 16516072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern views of diabetic angiopathy of the lower limbs (epidemiology, risk factor, etiopathogenesis, atherosclerosis of diabetes mellitus). Part I].
    Losev RZ; Kulikova AN
    Angiol Sosud Khir; 2005; 11(3):14-20. PubMed ID: 16439944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
    Di Marzio D; Mohn A; Mokini ZH; Giannini C; Chiarelli F
    Horm Metab Res; 2006 Nov; 38(11):691-705. PubMed ID: 17111296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular complications of diabetes: A narrative review.
    Lu Y; Wang W; Liu J; Xie M; Liu Q; Li S
    Medicine (Baltimore); 2023 Oct; 102(40):e35285. PubMed ID: 37800828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus.
    Galla JM; Nicholls SJ
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):85-93. PubMed ID: 19105770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.
    Blomster JI; Chow CK; Zoungas S; Woodward M; Patel A; Poulter NR; Marre M; Harrap S; Chalmers J; Hillis GS
    Diabetes Obes Metab; 2013 Nov; 15(11):1008-12. PubMed ID: 23675676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and the incidence of deep vein thrombosis after total knee arthroplasty: a retrospective study.
    Wang S; Zhao Y
    J Arthroplasty; 2013 Apr; 28(4):595-7. PubMed ID: 23153599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.
    Soma P; Pretorius E
    Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus.
    Simić I; Pećin I; Tedeschi-Reiner E; Zrinsćak O; Sućur N; Reiner Z
    Coll Antropol; 2013 Sep; 37(3):783-7. PubMed ID: 24308217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.
    Ajjan RA; Grant PJ
    Diab Vasc Dis Res; 2006 Dec; 3(3):147-58. PubMed ID: 17160909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome studies in type 2 diabetes.
    Hanefeld M
    Curr Med Res Opin; 2005; 21 Suppl 1():S41-8. PubMed ID: 15811198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy in type 2 diabetes mellitus.
    Angiolillo DJ
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.
    Nandish S; Wyatt J; Bailon O; Smith M; Oliveros R; Chilton R
    Am J Cardiol; 2011 Aug; 108(3 Suppl):42B-51B. PubMed ID: 21802580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of GLP-1 and GLP-1-based therapies: implications for the cardiovascular continuum in diabetes?
    Burgmaier M; Heinrich C; Marx N
    Diabet Med; 2013 Mar; 30(3):289-99. PubMed ID: 22804451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.